Open AccessCUTANEOUS ERUPTION IN COVID-19 IN TWO CASES: SIDE EFFECTS DRUGS OR VIRAL MANIFESTATION?
Author(s) -
Mariam Lagrine,
Karima El Fakiri,
Nourredine Rada,
Ghizlane Draïss,
Mohammed Bouskraoui,
S. Amal
Publication year - 2020
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/11843
Subject(s) - azithromycin , covid-19 , medicine , integumentary system , chloroquine , dermatology , viral infection , disease , infectious disease (medical specialty) , immunology , virology , pathology , virus , antibiotics , malaria , biology , outbreak , microbiology and biotechnology
It has been documented that COVID-19 can induce a significant systemic inflammatory response, potentially attending organ injury. The integumentary system may be similarly affected. The cutaneous manifestations in COVID-19 are largely unknown but case reports and studies will aid further understanding the association of COVID-19 disease progression and dermatological manifestations. Here we report two cases of patients, Hospitalized in pediatric department of Center hospital university of Mohamed VI, Marrakesh, Morocco presenting cutaneous eruptions after SARS-CoV-2 infection treated with chloroquine and azithromycin and literature review.